For: | Engin A, Gonul II, Engin AB, Karamercan A, Sepici Dincel A, Dursun A. Relationship between indoleamine 2,3-dioxygenase activity and lymphatic invasion propensity of colorectal carcinoma. World J Gastroenterol 2016; 22(13): 3592-3601 [PMID: 27053851 DOI: 10.3748/wjg.v22.i13.3592] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v22/i13/3592.htm |
Number | Citing Articles |
1 |
Daniel J. Lin, James C. K. Ng, Lei Huang, Max Robinson, James O’Hara, Janet A. Wilson, Andrew L. Mellor. The immunotherapeutic role of indoleamine 2,3‐dioxygenase in head and neck squamous cell carcinoma: A systematic review. Clinical Otolaryngology 2021; 46(5): 919 doi: 10.1111/coa.13794
|
2 |
Lizbeth Perez‐Castro, Roy Garcia, Niranjan Venkateswaran, Spencer Barnes, Maralice Conacci‐Sorrell. Tryptophan and its metabolites in normal physiology and cancer etiology. The FEBS Journal 2023; 290(1): 7 doi: 10.1111/febs.16245
|
3 |
Bohuslav Melichar, Klára Hrůzová, Lenka Kujovská Krčmová, Lenka Javorská, Eliška Pešková, Dagmar Solichová, Radomír Hyšpler, Eva Malířová, Milan Vošmik, Marie Bartoušková, Dušan Klos, Hana Študentová. Association of peripheral blood cell count-derived ratios, biomarkers of inflammatory response and tumor growth with outcome in previously treated metastatic colorectal carcinoma patients receiving cetuximab. Pteridines 2017; 28(3-4): 221 doi: 10.1515/pterid-2017-0016
|
4 |
Lukas Lanser, Patricia Kink, Eva Maria Egger, Wolfgang Willenbacher, Dietmar Fuchs, Guenter Weiss, Katharina Kurz. Inflammation-Induced Tryptophan Breakdown is Related With Anemia, Fatigue, and Depression in Cancer. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.00249
|
5 |
Ayse Basak Engin, Riza Onder Gunaydin, Sacit Altug Kesikli, Dietmar Fuchs, Ali Sefik Hosal. Serum neopterin concentrations and tryptophan degradation pattern in patients with late stage larynx carcinoma. Pteridines 2017; 28(2): 91 doi: 10.1515/pterid-2017-0004
|
6 |
Annabel Meireson, Inès Chevolet, Eva Hulstaert, Liesbeth Ferdinande, Piet Ost, Karen Geboes, Marc De Man, Dirk Van de Putte, Laurine Verset, Vibeke Kruse, Pieter Demetter, Lieve Brochez. Peritumoral endothelial indoleamine 2, 3-dioxygenase expression is an early independent marker of disease relapse in colorectal cancer and is influenced by DNA mismatch repair profile. Oncotarget 2018; 9(38): 25216 doi: 10.18632/oncotarget.25393
|
7 |
Ayse Basak Engin, Atilla Engin. Obesity and Lipotoxicity. Advances in Experimental Medicine and Biology 2024; 1460: 629 doi: 10.1007/978-3-031-63657-8_21
|
8 |
Moein Ala. The footprint of kynurenine pathway in every cancer: a new target for chemotherapy. European Journal of Pharmacology 2021; 896: 173921 doi: 10.1016/j.ejphar.2021.173921
|
9 |
Ana Sebio, Breelyn A Wilky, Vicki L Keedy, Robin L Jones. The Current Landscape of Early Drug Development for Patients with Sarcoma in the Immunotherapy Era. Future Oncology 2018; 14(12): 1197 doi: 10.2217/fon-2017-0565
|
10 |
Lieve Brochez, Ines Chevolet, Vibeke Kruse. The rationale of indoleamine 2,3-dioxygenase inhibition for cancer therapy. European Journal of Cancer 2017; 76: 167 doi: 10.1016/j.ejca.2017.01.011
|
11 |
Asami Hagiwara, Yoshiyasu Nakamura, Rumi Nishimoto, Satoko Ueno, Yohei Miyagi. Induction of tryptophan hydroxylase in the liver of s.c. tumor model of prostate cancer. Cancer Science 2020; 111(4): 1218 doi: 10.1111/cas.14333
|
12 |
Jinhao Liu, Jikun Wang, Xueqian Ma, Yang Feng, Yanlei Chen, Yanping Wang, Dong Xue, Shifeng Qiao. <p>Study of the Relationship Between Serum Amino Acid Metabolism and Lymph Node Metastasis in Patients with Colorectal Cancer</p>. OncoTargets and Therapy 2020; : 10287 doi: 10.2147/OTT.S273107
|
13 |
Ayse Basak Engin, Atilla Engin. Protein Kinase-mediated Decisions Between Life and Death. Advances in Experimental Medicine and Biology 2021; 1275: 339 doi: 10.1007/978-3-030-49844-3_13
|
14 |
Eva Ott, Linda Bilonda, Delphine Dansette, Cécile Deleine, Emilie Duchalais, Juliette Podevin, Christelle Volteau, Jaafar Bennouna, Yann Touchefeu, Pierre Fourquier, Wassila El Alami Thomas, Jérome Chetritt, Stéphane Bezieau, Marc Denis, Claire Toquet, Jean-François Mosnier, Anne Jarry, Céline Bossard. The density of Tbet+ tumor-infiltrating T lymphocytes reflects an effective and druggable preexisting adaptive antitumor immune response in colorectal cancer, irrespective of the microsatellite status. OncoImmunology 2019; 8(4): e1562834 doi: 10.1080/2162402X.2018.1562834
|
15 |
Diwakar Davar, Nathan Bahary. Modulating Tumor Immunology by Inhibiting Indoleamine 2,3-Dioxygenase (IDO): Recent Developments and First Clinical Experiences. Targeted Oncology 2018; 13(2): 125 doi: 10.1007/s11523-017-0547-9
|
16 |
Cem Horozoglu, Mehmet Tolgahan Hakan, Dilara Sonmez, Asli Yildiz, Seyda Demirkol, Fikret Aktas, Sidar Bagbudar, Ozlem Kucukhuseyin, Soykan Arikan, Filiz Akyuz, Ilhan Yaylim. IDO1-mediated catabolism of tryptophan in gastric tumors: Its potential role in the axis of histopathology, differentiation and metastasis. Pathology - Research and Practice 2024; 263: 155655 doi: 10.1016/j.prp.2024.155655
|
17 |
Annabel Meireson, Michael Devos, Lieve Brochez. IDO Expression in Cancer: Different Compartment, Different Functionality?. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.531491
|